Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.45
Bid: 18.00
Ask: 18.45
Change: 0.275 (1.51%)
Spread: 0.45 (2.50%)
Open: 18.00
High: 18.45
Low: 18.00
Prev. Close: 18.175
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of NGSoft

1 Mar 2021 07:00

RNS Number : 6021Q
BATM Advanced Communications Ld
01 March 2021
 

LEI: 213800FLQUB9J289RU66

1 March 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Update on Sale of NGSoft

 

Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021.

 

The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021.

 

NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEIFWAEFSEDE
Date   Source Headline
24th Mar 20099:45 amRNSHolding(s) in Company
17th Mar 20096:30 pmRNSFinal Results - Replacement
17th Mar 20091:49 pmRNSDividend Declaration
17th Mar 20097:00 amRNSFinal Results
5th Feb 20097:00 amRNSNotice of Results
7th Jan 20097:00 amRNSTrading Update
9th Dec 20087:00 amRNSFirst Medical Equipment Order
1st Dec 20084:36 pmRNSPrice Monitoring Extension
3rd Nov 20087:00 amRNSInterim Management Statement
17th Sep 20088:52 amRNSDirector/PDMR Shareholding
27th Aug 20085:26 pmRNSDirector/PDMR Shareholding
27th Aug 20082:02 pmRNSDirector/PDMR Shareholding
26th Aug 20087:00 amRNSInterim Results
20th Aug 200810:42 amRNSResult of EGM
29th Jul 20089:00 amRNSNotice of Results
8th Jul 20087:00 amRNSRecommended Offer
8th Jul 20087:00 amRNSOffer for Vigilant Technology
23rd Jun 20084:03 pmRNSDirector/PDMR Shareholding
16th Jun 20082:54 pmRNSResult of AGM
16th Jun 20087:00 amRNSAGM Statement and Trading Upd
19th May 20087:00 amRNSContract Win
14th May 20087:00 amRNSAnnual Report and Accounts
12th May 20081:16 pmRNSHolding(s) in Company
16th Apr 200811:49 amRNSDirector/PDMR Shareholding
10th Apr 20085:09 pmRNSDirector/PDMR Shareholding
1st Apr 20089:47 amRNSDirector/PDMR Shareholding
1st Apr 20087:00 amRNSInterim Management Statement
4th Mar 20084:16 pmRNSDividend Declaration
21st Feb 20087:00 amRNSFinal Results
3rd Jan 20087:00 amRNSTrading Statement
25th Sep 20075:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSDirector/PDMR Shareholding
10th Sep 20077:00 amRNSInterim Results
15th Aug 200712:15 pmRNSNotice of Results
30th Jul 200711:25 amRNSResult of AGM
26th Jul 20077:00 amRNSAGM & Trading Update
18th Jun 20071:30 pmBUSThe T-Marc 300 series product family is the first multi-port customer-located demarcation device to provide extensive management and test features for Ethernet, MPLS/VPLS and IP networks. With purpose-built demarcation and service extension capabilities,
14th Jun 20077:01 amRNSHolding(s) in Company
7th Jun 200710:50 amRNSDirector/PDMR Shareholding
1st Jun 20075:13 pmRNSDirector/PDMR Shareholding
31st May 20077:15 pmBUSTelco Systems Signs Agreement with Major Japanese Distributor
21st May 20077:00 amRNSDistribution Agreement
2nd May 20077:00 amRNSContract Win
1st May 20079:29 amRNSHolding(s) in Company
1st May 20079:22 amRNSHolding(s) in Company
16th Apr 200710:51 amRNSHolding(s) in Company
12th Apr 200712:30 pmRNSDirector/PDMR Shareholding
11th Apr 20072:00 pmBUSTelco Systems Total FTTH Solution Now Approved for USDA's Rural Utilities Service
27th Mar 20077:56 amRNSHolding(s) in Company
19th Mar 20073:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.